Literature DB >> 32275127

Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis.

Brett R Loman1, Chandra L Shrestha1, Rohan Thompson2, Judith A Groner3, Asuncion Mejias4,5, Kathryn L Ruoff6, George A O'Toole6, Michael T Bailey1, Benjamin T Kopp1,2.   

Abstract

BACKGROUND: Mechanisms that facilitate early infection and inflammation in cystic fibrosis (CF) are unclear. We previously showed that young CF children with secondhand smoke exposure (SHSe) have increased susceptibility to respiratory infections. We aimed to define the impact of SHSe and other external factors upon the fecal bacteriome in early CF.
METHODS: Twenty CF infants and children were enrolled, clinical data recorded, and hair nicotine measured as an objective surrogate of SHSe. Fecal samples were collected at clinic visits and bacteriome 16S rRNA gene sequencing performed.
RESULTS: SHSe was associated with increased alpha diversity and increased relative abundance of Acinetobacter and Akkermansia, along with decreased Bifidobacterium and Lactobacillus. Recent antibiotic exposure predicted bacterial population structure in children less than 2 years of age and was associated with decreased Bacteroides relative abundance. Age was the strongest predictor of overall fecal bacterial composition and positively associated with Blautia and Parabacteroides. Weight for length was negatively associated with Staphylococcus relative abundance.
CONCLUSIONS: SHSe and other external factors such as antibiotics appear to alter fecal bacterial composition in young CF children, but the strongest predictor of overall composition was age. These findings have implications for understanding the intestinal microbiome in young CF children.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  cystic fibrosis (CF)

Mesh:

Substances:

Year:  2020        PMID: 32275127      PMCID: PMC7593804          DOI: 10.1002/ppul.24766

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  47 in total

1.  Gut Microbiome-Induced Shift of Acetate to Butyrate Positively Manages Dysbiosis in High Fat Diet.

Authors:  Xu Si; Wenting Shang; Zhongkai Zhou; Padraig Strappe; Bing Wang; Anthony Bird; Chris Blanchard
Journal:  Mol Nutr Food Res       Date:  2018-01-08       Impact factor: 5.914

2.  Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.

Authors:  Katherine M Antosca; Diana A Chernikova; Courtney E Price; Kathryn L Ruoff; Kewei Li; Margaret F Guill; Natalie R Sontag; Hilary G Morrison; Shuyu Hao; Mitchell L Drumm; Todd A MacKenzie; Dana B Dorman; Lynn M Feenan; Molly A Williams; John Dessaint; Irene H Yuan; Brian J Aldrich; Lisa A Moulton; Lily Ting; Ana Martinez-Del Campo; Edward J Stewart; Margaret R Karagas; George A O'Toole; Juliette C Madan
Journal:  J Bacteriol       Date:  2019-07-24       Impact factor: 3.490

3.  Adult-type pulmonary function tests in infants without respiratory disease.

Authors:  R Castile; D Filbrun; R Flucke; W Franklin; K McCoy
Journal:  Pediatr Pulmonol       Date:  2000-09

4.  The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study.

Authors:  Moana Mika; Insa Korten; Weihong Qi; Nicolas Regamey; Urs Frey; Carmen Casaulta; Philipp Latzin; Markus Hilty
Journal:  Lancet Respir Med       Date:  2016-05-11       Impact factor: 30.700

5.  Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.

Authors:  Benjamin T Kopp; Rohan Thompson; Jeeho Kim; Robert Konstan; Alejandro Diaz; Bennett Smith; Chandra Shrestha; Lynette K Rogers; Don Hayes; Dmitry Tumin; Frederick W Woodley; Octavio Ramilo; Don B Sanders; Judith A Groner; Asuncion Mejias
Journal:  Thorax       Date:  2019-01-19       Impact factor: 9.139

6.  Sewage reflects the microbiomes of human populations.

Authors:  Ryan J Newton; Sandra L McLellan; Deborah K Dila; Joseph H Vineis; Hilary G Morrison; A Murat Eren; Mitchell L Sogin
Journal:  MBio       Date:  2015-02-24       Impact factor: 7.867

Review 7.  The Microbiome in Cystic Fibrosis.

Authors:  Yvonne J Huang; John J LiPuma
Journal:  Clin Chest Med       Date:  2015-12-23       Impact factor: 2.878

Review 8.  Oxidative and endoplasmic reticulum stress in respiratory disease.

Authors:  Alice C-H Chen; Lucy Burr; Michael A McGuckin
Journal:  Clin Transl Immunology       Date:  2018-06-13

9.  Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances.

Authors:  Raphaël Enaud; Katarzyna B Hooks; Aurélien Barre; Thomas Barnetche; Christophe Hubert; Marie Massot; Thomas Bazin; Haude Clouzeau; Stéphanie Bui; Michael Fayon; Patrick Berger; Philippe Lehours; Cécile Bébéar; Macha Nikolski; Thierry Lamireau; Laurence Delhaes; Thierry Schaeverbeke
Journal:  J Clin Med       Date:  2019-05-10       Impact factor: 4.241

10.  Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.

Authors:  Ohad Manor; Roie Levy; Christopher E Pope; Hillary S Hayden; Mitchell J Brittnacher; Rogan Carr; Matthew C Radey; Kyle R Hager; Sonya L Heltshe; Bonnie W Ramsey; Samuel I Miller; Lucas R Hoffman; Elhanan Borenstein
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

View more
  7 in total

1.  The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Madina Kozhieva; Natalia Naumova; Tatiana Alikina; Alexey Boyko; Valentin Vlassov; Marsel R Kabilov
Journal:  Life (Basel)       Date:  2021-01-14

Review 2.  The Gut-Lung Axis in Cystic Fibrosis.

Authors:  Courtney E Price; George A O'Toole
Journal:  J Bacteriol       Date:  2021-08-02       Impact factor: 3.476

Review 3.  Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions.

Authors:  Rachel Y Tam; Josie M van Dorst; Isabelle McKay; Michael Coffey; Chee Y Ooi
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 4.  Probiotics Administration in Cystic Fibrosis: What Is the Evidence?

Authors:  Susanna Esposito; Ilaria Testa; Elena Mariotti Zani; Daniela Cunico; Lisa Torelli; Roberto Grandinetti; Valentina Fainardi; Giovanna Pisi; Nicola Principi
Journal:  Nutrients       Date:  2022-07-30       Impact factor: 6.706

Review 5.  PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy.

Authors:  Dave P Nichols; Scott H Donaldson; Carla A Frederick; Steven D Freedman; Daniel Gelfond; Lucas R Hoffman; Andrea Kelly; Michael R Narkewicz; Jessica E Pittman; Felix Ratjen; Scott D Sagel; Margaret Rosenfeld; Sarah Jane Schwarzenberg; Pradeep K Singh; George M Solomon; Michael S Stalvey; Shannon Kirby; Jill M VanDalfsen; John P Clancy; Steven M Rowe
Journal:  J Cyst Fibros       Date:  2021-02-19       Impact factor: 5.482

6.  Metabolomics profiling of tobacco exposure in children with cystic fibrosis.

Authors:  Benjamin L Wisniewski; Chandra L Shrestha; Shuzhong Zhang; Rohan Thompson; Myron Gross; Judith A Groner; Karan Uppal; Octavio Ramilo; Asuncion Mejias; Benjamin T Kopp
Journal:  J Cyst Fibros       Date:  2020-05-30       Impact factor: 5.482

Review 7.  What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?

Authors:  Josie M van Dorst; Rachel Y Tam; Chee Y Ooi
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.